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Abstract 
Over the last couple of decades non-nutritional bioactive compounds from 
plants and their biological effects have received attention. Phytoestrogens, also 
called “plant estrogens”, with their similar structure to estradiol, act with es-
trogenic effects when imbibed. The compounds that have received considera-
ble interest are, among others, the Isoflavones, of which significant quantities 
can be found in most members of the family Leguminosae (Fabaceae). Soy, a 
member of the leguminosae, is the main nutritional source to these phytoes-
trogenic isoflavones. Isoflavones are commonly consumed in East Asia but less 
so in the western world. It is highly suggested that the health effects of isofla-
vones are dependent on the consumer’s ability to digest the substances. This 
article reviews these estrogen active, polyphenolic compounds present in soy- 
and bovine milk for the comparison of isoflavone content, bioavailability, and 
isoflavone related health effects. The mechanisms are also reviewed. This is 
done for understanding the eventual importance of these phytoestrogens as a 
part of the diet, and why variation of sources may be of interest for parts of the 
population. Preliminary study shows phytoestrogen having a largely positive 
health effect. But only approximately 30-50% of the population are so called 
“equol-producers” and for the other half soy may not be an optimal isoflavone 
source and instead bovine milk may serve as an alternative and/or additional 
dietary source, as isoflavone metabolites have been traced in cow’s milk. 
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Sammanfattning  
De senaste decennierna har det funnits ett ökat intresse för växters 
bioaktiva ämnen och biologiska effekt. Fytoöstrogen, eller ”växtöstro-
gen”, med liknande struktur som östradiol, verkar med likhet på krop-
pen som dess eget östrogen vid konsumtion. De kemiska föreningarna 
som det har intresserats mest för har bland annat varit isoflavonerna, 
vilka höga koncentrationer går att finna i växter från familjen Fabaceae. 
Soja är medlem i familjen och fungerar också som, för människan, den 
största nutritionella källan. Isoflavoner konsumeras i högre grad i Osta-
sien, jämfört med västvärlden. Det har föreslagits att isoflavonernas 
hälsoeffekter är i stark relation till konsumentens förmåga att bryta ner 
dessa ämnen till deras metaboliter, bland annat equol som har stark 
likhet med östradiol. Denna artikel sammanfattar dessa östrogenaktiva 
polyfenolers förekomst, hälsoeffekt och biotillgänglighet i soja- och 
komjölk. Mekanismer granskas också. Detta är gjort för att öka förståel-
sen kring varför det kan vara nödvändigt med fytoöstrogener i dieten 
och varför det eventuellt skulle vara viktigt med varierande källor till 
dessa. Vid en preliminär granskning verkar isoflavoners hälsoeffekter 
överlag vara positiva. Bara ca 30-50% av befolkningen kan producera 
equol från de isoflavoner som finns i soja, för den andra delen kanske 
soja trots allt inte är den optimala källan till isoflavoner utan istället 
kan kanske komjölk vara en alternativ källa. Detta då man har kunnat 
hitta nivåer av dessa isoflavonmetaboliter i mjölk.  
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Abbreviations 
 
IF, isoflavone  
IFA, isoflavone aglycone  
IFG, isoflavone glucosides  
ERα, estrogen receptor alpha  
ERβ, estrogen receptor beta  
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1 Introduction 
1.1 Background  
The soybean originates from China and has been a central part of the tradi-
tional East Asian diet. Hormone induced cancers such as colon cancer, breast 
cancer, prostate cancer, along with cardiovascular diseases and menopausal 
symptoms have historically been recorded to be fewer in East Asian popula-
tions compared to those in the western world (Adlercreutz et., al, 1997). 
Hence the association of soy being a health food might be possible. The health 
aspects may be many, likewise the reasons for consumption, such as the bean 
containing a large amount of unsaturated fatty acids including the essential 
fatty acid alpha-linolenic acid (He et., al, 2013). Soy also contains significant 
amounts of all the essential amino acids (Hoffman, 2004).  Though more re-
cently interest has fallen on other bioactive compounds, such as those with 
hormonal activity. One such group of compounds is called phytoestrogens. 
These “plant-hormones” exist in most plants in different variations, and work 
as part of the plants own defense mechanism. The most common phytoestro-
gens are isoflavones (IFs) (Lundh, 1990), a group of compounds that are 
mostly found in leguminous plants in the Asian diets and less so in the foods 
of the western world. Though milk based on the legume soy is becoming more 
popular in the western world as a substitute for its animal counterparts.  De-
spite Euro-American/Asian differences in isoflavone consumption, high levels 
of these phytoestrogens can be found in animal feed all around the world. The 
effect of silage type on the IF content in milk may therefore be interesting. 
The content of IF in milk may even be important when the benefits of milk are 
discussed (Steinshamn et al., 2008).  IFs are found in high concentrations in 
forage legumes, with high values reached in different types of clover, com-
monly used as silage. As legumes are nitrogen fixating through bacterial sym-
biosis they have become a popular organic alternative for nitrogen-binding in 
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soil, as to compared to synthetic fertilizers. The interest for forage legumes as 
animal feed has therefore increased (Santos-Buelga et al., 2011). 
1.2 Aim  
The aim of this report was to compare the content, bioavailability and health 
effects of IFs in soymilk and cow’s milk in order to more generally illustrate 
the health effects and availability of IFs in human nutrition. 
1.3 Methods  
This is a theoretical report based on information gathered from published 
scientific articles. There are many published articles regarding soy IFs and 
their concentrations in soy products, consumption and health benefits. Prob-
lematic areas during this work have been that, despite some research on the 
IF effect on animals, there has only recently been an interest in the IF content 
in animal products consumed by humans. The literature is therefore limited. 
Also research on the digestion of IF and mapping of the mechanism of action 
in the body is also lacking, possibly due to the supposedly wide spread action 
of the components. The United States Department of Agriculture (USDA), pro-
vides the most accessible on-line database for the IF content in different food-
stuff.  
 
 
 
10 
 
2 Phytoestrogen and isoflavone 
characteristics 
2.1 Phytoestrogens 
Phytoestrogens are a group of naturally occurring, plant-derived compounds 
that have been shown to have estrogenic properties, binding to the estrogen 
receptors (ER) and modulating gene expression. They can be divided into 
three main classes: isoflavones (IFs), coumestans and lignans (Kurzer et. Al., 
1997). Although all being non-steroidal they share remarkable resemblance 
in molecular structures and activity with mammalian estrogens, synthetic 
estrogens and anti-estrogens and can therefore bind to ERs (Duncan et al., 
2003).  
Phytoestrogens are found in most plant material, such as berries, grains, nuts 
and fruits (Patisaul, 2010). Coumestans have been found in many important 
types of forage, while the IFs are known to be present in red- and subterrane-
an clover (Guggolz, 1961). In the plants they work as an antimicrobial defense 
to combat pathogens and in legumes the IFs are involved in the nitrogen-
fixating abilities, by stimulating the soil-microbe rhizobium to form nitrogen-
fixing root nodules (Subramanian et al., 2006). There are many peer-reviewed 
publications discussing the relationships between health impacts and phy-
toestrogen consumption and digestion, and the strongest relations have been 
seen in high IF consuming populations (Bakker, 2004). 
2.2 Isoflavones 
Isoflavones and their derivatives are similar to 17-beta estradiol both in 
structure and function (Kleijn et al., 2002). See Figure 1 for a schematic de-
scription of the different IFs. They are a group of secondary plant metabolites 
belonging to the isoflavonoids, which in turn is a subgroup of the flavonoids. 
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The IF sources are generally more limited as to those of other phytoestrogens, 
as they are more abundant in plants belonging to the Fabacae family 
(Patisaul, 2010). Soy is for humans essentially the only relevant nutritional 
source of IF’s compounds. There are however other high content IF sources, 
although these are not foodstuff for humans, but are rather forage legumes 
widely used as cattle feed, such as red clover (Messina et al., 2006).  
2.3 Chemical structure of the isoflavones in soy and clover 
There are three main IFs in soy; genistein (4’,5,7-trihydroxyisoflavone),      
daidzein (4’,7-dihydroxyisoflavone), and glycitein (4’,7-dihydroxy-6-metho- 
xyisoflavone), (Figure 1)(Kurzer, 1997). They can be found in different conju-
gated forms depending on conditions, e.g. digestion, product handling and 
processing. The forms of the IFs in soy are the more biologically active agly-
cones (IFA) (genistein, daidzein and glycitein), and the non-active 7-O-
glucosides (IFG) (genistin, daidzin and glycitin) (Heinonen et al., 1999). The 
IFGs in soy and other plants are conjugated mainly with glucose, and 6”-O-
malonyl or 6”-O-acetylglucose. 
Soy and clover have different IF profiles. The commonest IFs in clover are the 
less estrogenic precursors and 4’-methyl ethers of daidzein and genistein; 
biochanin A (5,7-dihydroxy-4’methoxyisoflavone) and formononetin (7-
hydroxy-4’-methoxyisoflavone), respectively (Kurzer, 1997; Heinonen, 1999).  
IFAs described above have similar biological activities, though at different 
degree, of which daidzein can be converted into a highly active metabolite 
(Jia, 2004).  
2.4 Isoflavone metabolites 
By the colonic microflora genistein may be metabolized primarily into p-ethyl 
phenyl and daidzein to equol (4’,7-dihydroxyisoflavan) and/or to O-
desmethylangolensin (O-DMA), p-ethylphenol being non-estrogenic (Tham et 
al., 1998). Equol is the phytoestrogen of special interest, as it is similar in 
structure to estradiol, (Figure 2), and is suggested to have, among other posi-
tive health effects, strong cancer preventative effects (Setchell, 2006). With its 
chiral center positioned at C-3, equol is a molecule that exists as the enantio-
mers R-equol and S-equol, where S-equol has high affinity to the estrogen 
receptor β (ER- β), therefore having a strong estrogenic effect on the organ-
isms (Setchell, 2005). It is this molecule´s ability to exist in two enantiomer 
forms that distinguishes it from the other IFs mentioned. Other IF metabolites 
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do however exist, but with less activity than equol (Heinonen et al., 1999).  
 
Figure 1. Chemical structure of isoflavones, as aglycones, glucosides, and the precursors of the 
aglycones genistein and daidzein; biochanin A and formonoetin, respectively.  
 
 
 
 
 
 
 
Figure 2.Chemical structure of (A) equol and (B) estradiol.  
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3 Absorption, metabolism and mechanism of 
action   
3.1 Absorption and metabolism 
The metabolism of the IFs is primarily carried out by intestinal bacteria. 
There has been no observation of absorption by the epithelium of the intact 
IFGs, as they have higher molecular weight and hydrophilicity than their agly-
cones (Hendrich, 2002; Yuan et al., 2007).  When ingested, the inactive IFGs 
are exposed to acidic and enzymatic hydrolysis by glycosidases in the small 
intestine (Figure 3)(Heinonen et al., 1999). The IFAs may be metabolized fur-
ther through demethylation and reduction by gut bacteria.  
Biochanin A can be demethylated in the liver to genistein that may continue 
tometabolize in the intestine to   p- ethylphenol and other organic acids, e.g. 
acetic and melonic acids, by ring cleavage (Pfitscher et al., 2008). Formo-
nonetin is mainly demethylated to daidzein, which may subsequently be con-
verted through reduction to become equol in the intestine. An alternative 
path that does not include the demethylation, involves reduction and ring 
fission to O-DMA. Other pathways may exist. 
The IFAs and metabolites formed are then excreted via the urine or absorbed 
in the intestine and transported in the blood plasma (Heinonen et al., 1999). A 
small part of the aglycones enters the enetrohepatic circulation. In the liver 
they go through hydroxylation and conjugation to other more hydrophilic 
metabolites that can be secreted via the urine.   
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Figure 3. Schematic description of the metabolism and absorption of the IFAs and IFGs. O-DMA= 
0-desmethylangolensin. 
Since the metabolism of the IFs varies there is a limitation when quantifying 
the content in urine and/or plasma as a determination of soy ingestion (Hen-
drich, 2002). Individuals that can metabolize IFs into equol are referred to as 
“equol producers”. The extent of the metabolic capacity varies among indi-
viduals as only about 30-50% of the total human population has the bacteria 
able to metabolize equol. Other mammals have not shown the same variety as 
humans in the ability to produce equol. This variation among the populations 
is believed to depend on multiple factors such as the bacterial composition in 
the intestinal tract, pH and redox potential in the small- and large intestine 
(Tärnvik, 2001).  Antibiotic treatments have been recorded to eliminate equol 
production in individuals and germfree animals do not excrete the IF metabo-
lites (Wiseman et al., 2004) 
The nature of the diet influences the microflora diversity and their activity on 
metabolizing the IFs. It has ben suggested that a high total intake of dietary 
lipids may decrease the capacity to synthesize equol by the microbial flora 
(Rowland, 1999). The relationship between IFs and food matrix has however 
not been studied in any greater extent (Hendrich, 2002).  
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3.2 Mechanisms of action 
 
Genistein is the most studied phytoestrogen, as it is also the most biological 
active one (Tärnvik et al., 2001).  To what extent the IFs can provide health 
effects depend on absorption, metabolism, cellular distribution and bioavail-
ability (Hendrich, 2002). The metabolites have gained lots of interest as it is 
strongly suggested that those who are equol producers may have particular 
or extensive benefit from soy (Heinonen, 2003). The health effects are caused 
by different mechanisms of which can be described as those binding to ERs 
causing estrogenic or antiestrogenic effects, and those inhibit enzyme activity 
affecting production of hormones or hormone binding protein (Tärnivik et al., 
2001). But there are also effects that are not hormone related, such as being 
antioxidants.  
When studying the health effects of phytoestrogens, the ligands ability to an-
tagonize the growth- promoting action of 17β- estradiol has received interest 
(Matsumura et,al., 2005). Genistein has at low concentrations been observed 
to enhance cell growth through ER, whilst at high concentrations (>10uM) 
cell growth is inhibited. IFs are generally weaker compared to the endoge-
nous estrogen, but may be found in plasma concentrations 100-fold higher 
(Tham et al., 1998). The competition that arises between the phytoestrogens 
and the endogeneous estrogen for the ER may explain the antiestrogenic ac-
tivity. This activity is a common behavior for many weak estrogens, and 
means that they bind to block estrogen activity that may cause hormone re-
lated diseases. IFs bind to ERβ and ERα with a diverse affinity compared to 
the endogenous estrogens that generally show no difference to affinity 
(Tärnvik et al., 2001). This could mean a targeting effect on body tissue with 
higher proportion ERβ such as bone and thymus in female, and prostate and 
vascular in male.  
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Evidence supports that the IFs metabolites act with greater effect than those 
of their parent compounds (Rowland, 1999). Equol has been found to be 
three times as estrogenic in an endometrial tumor line as its parental com-
pound daidzein. Also, equol decreased the estrogen-responsive pS2 gene ex-
pression in MCF7 (a breast cancer cell line), daidzein did not show this activi-
ty. The S-equol enantiomer selectively binds to the ERβ with ca20% as much 
affinity as 17β- estradiol (Setchell et al., 2005). Equol is unique as it has selec-
tive estrogen action while also having the ability to be an antagonist of andro-
gen action. The mechanisms are however not fully understood. The degree of 
effect and biological behavior by the IFs consumed has been shown to depend 
on the consumption amount and the individual’s levels of endogenous estro-
gen (Setchell, 1999).  Equol is also a more potent antioxidant compared to 
daidzein. 
Further studies upon the mechanism of action are necessary in order to pin 
point the exact activity providing the eventual health effects caused by the 
discussed Isoflavones, as there is some confusion within the discussion of the 
subject  (Matsmura, 2005). 
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4 Occurrence of isoflavones and their 
metabolites in soymilk  
4.1 Isoflavone content in soybean  
As mentioned, the IFs come in different chemical forms, but the IFs in soy 
occur primarily as β-glucosides in non-fermented soy foods. Only 2% occur as 
the biologically active aglycones. The distribution of IFs in soy is 50% 
genistein, 40% daidzein and 10% glycitein (Messina, 2010).  
According to USDA (U.S Department of Agriculture) the genistein, daidzein 
and glycitein content in unprocessed mature soybeans is 81 mg/100g, 62 
mg/100g and 15 mg/100g edible portion, respectively (USDA Database for 
the Isoflavone Content of Selected Foods, 2008). The data presented by USDA 
is collected from articles published in referred journals since 1999 containing 
analytic data for IFs in food. All data presented is converted to represent val-
ues for the biologically active IFAs. Mazur (1998) presents phytoestrogen 
levels in plant-derived foods given from a method using isotope dilution gas 
chromatography- mass spectrometry (ID-GC-MS-SIM), recognizing this meth-
od for being more specific when quantifying small concentrations of phytoes-
trogens compared to the commonly used high-performance liquid chroma-
tography (HPLC) (Mazur, 1998).   
IF concentrations in soy beans as well as in the soy end product will vary de-
pending on several factors, such as location, daylight, stress and conditions of 
harvest as well as storage and product handling. In any plant material the IF 
content will vary depending on several factors. As Seguin et al. (2004) sug-
gests; environmental factors do have great impact on IFs concentrations in 
soybean seeds (Seguin et al., 2004). 
18 
 
 
4.2 Occurrence in soymilk 
The IFGs generally remain unmodified during food processing (Heinonen et 
al., 2003). Most IFs consumed in non-fermented soy foods, such as soymilk, 
are therefore not in the biologically active aglycone form. 
The genistein, daidzein and glycitein content in soymilk (low fat, with added 
calcium, vitamins A and D) are 1.51 mg/100g, 1.01 mg/100g, 0.4 mg/100g 
edible portion respectively, reaching a total content of 2.56 mg IFs/100g. 
Nonfat soymilk contains less, with a total of 0.7mg IFs/100g (USDA Database 
for the Isoflavone Content of Selected Foods, 2008). 
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5 Occurrence of isoflavones and their 
metabolites in cow’s milk  
5.1 Occurrence in animal feed 
Most crops that are commonly used in large amounts as animal feed contain 
relatively high amounts of IFs (Lundh, 1990). The pasture forage legumes 
containing large amounts of IF are subterranean clover (Trifolium subterra-
neum), red clover (Trifolium pratense), soybean (Glycine max), and field bean 
(Vicia faba). In red clover the IF content is 0.5-2.5% of the dry matter. In 
green subterranean clover the content can be as much as 5% of the dry mat-
ter. The most common IFs in animal feed are formonoetin and biochanin A, 
followed by daidzein, genistein, glycitein, all mainly occurring as water-
soluble glycoside conjugates. An increased interest for nitrogen-fixating crops 
within the organic agriculture has resulted in the increased IF content in the 
animal feed.  
5.2 Occurrence in cow milk 
According to USDA there is no formononetin present in milk with 2% fat. The 
same finding is documented for the other IFs (USDA Database for the Isofla-
vone Content of Selected Foods, 2008).  
The phytoestrogens consumed by cattle are highly metabolized in the rumen 
(Steinshamn et al., 2008). IFs metabolites may therefore be present in the 
milk (Mustonen et al., 2009). The bovine’s digestion of IFs allows for equol 
production. The concentration varies greatly, and as a result of the feed fed to 
organically raised cows there may be higher concentration of the IF metabo-
lites in organic milk compared to non-organic.  
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The equol content has been measured to be 600-700μg/L in milk produced by 
cows given red clover silage feeding. These levels can be manipulated by har-
vest and feeding strategy. Biochanin A and formononetin are not found in any 
significant amount in soy. They are the main IFs in some clover, especially in 
clover grown in nitrogen poor soil. Depending on the conditions genistein is 
known to stimulate nitrogen-fixing bacteria (Bingham et, al., 1997).  
In Finland, Hoikkala et al. (2007) quantified the equol concentration commer-
cial skimmed Finnish milk and found concentration levels to be ca six times 
larger in organic milk compared to conventionally produced milk (411μg/L 
and 62μg/L, respectively) (Hoikkala et al., 2007). The higher content proba-
bly a result of higher legume content in the leys. Biochanin A and formonoetin 
were traced in the organic milk samples. 
5.3 Effects on the animal 
Phytoestrogens and their estrogenic activities were recognized first in the 
1940’s when an outbreak in Australia occurred with infertility in ewes graz-
ing on subterranean clover. It has been suggested that cattle are less sensitive 
to plant estrogens as they have not been recorded to show symptoms in the 
same degree as those seen in sheep (Lundh, 1990). This probably depends on 
the differences in metabolism and the degradation and conjugation rates af-
fecting the sensitivity of the animal. The IF effect on cattle are of interest and 
should be taken into consideration when evaluating the effect of feed and 
harvest strategies. 
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6 Dietary intakes of phytoestrogens and 
isoflavones 
 
Dietary intakes of phytoestrogens vary among populations. China and Japan 
have been known to have a higher intake of IFs (Setchell, 2006). The ability to 
produce equol has also ben seen to vary among the populations.  
Consumers with traditional East Asian diets have the highest intake phytoes-
trogens, of which the majority is IFs (ca25-100mg/d), compared to those con-
suming traditional west diets (Bakker, 2004). Ca 50-55% of adults in Asian 
countries produces S-equol (Setchell, 2006). A diet that provides such high 
levels phytoestrogens causes plasma levels much higher than the endogenous 
estrogen (Tärnvik et al., 2001).  
In standard Western diets, phytoestrogen content as a total is low. The IF 
intake of the average Western consumer is therefore also low (ca1-2mg/d) 
(Bakker, 2004). Only ca20-35% of Western adults produces S-equol from soy 
food or IFs supplements (Setchell, 2006).  However, vegans in Western coun-
tries have a relatively high IF intake (ca75mg/d) (Bakker, 2004). Vegetarians 
in the same regions have higher frequencies of equol producers, ca 59% 
(Setchell, 2006).  Consumers taking dietary phytoestrogen containing sup-
plements are also recorded to have a higher IF intake.  
In Scandinavia the total intake of phytoestrogens is relatively low, just a few 
hundred μg/day of which the majority is lignans from cereal, fruit, berries 
and vegetables (tärnvik, 2001).  
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7 Effects on human health 
Prevalent western diseases such as hormone induced cancers, cardiovascular 
diseases and osteoporosis, and menopausal symptoms have been document-
ed to be fewer in groups who consume more high IF content foods (Coward et 
al., 1993). Epidemiological studies regarding the associations between IF con-
sumption and health benefits have however, despite many supportive studies, 
not ben consistently positive. Ingested IFs have been linked to beneficial ef-
fects regarding cell growth, and there are many studies presenting positive 
effects with animal as test objects. 
7.1 Cancer 
Isoflavones have been suggested to decrease the risk of hormone induced 
cancers such as breast cancer and colon cancer.  
7.1.1 Breast cancer 
In western populations, breast cancer is the most common cancer in woman 
(Bingham et, al., 1997). Estrogen levels and breast cancer risk has ben strong-
ly associated with each other, levels that will vary depending estrogen activity 
related to ovarian function. Short menstrual cycles, elevated age of first preg-
nancy- and menopause are factors that determine an increased risk. These 
factors do vary between women in east- and western populations (Tärnvik et 
al., 2001). Women in Asia have even been recorded to have 20-30% lower 
plasma concentrations of the endogenous estrogens.  
There are epidemiological observations that show a significant lower risk of 
breast cancer in women from Asian populations compared to women in 
Western populations (Adlercreutz and Mazur, 1997). Focused observational 
studies have shown an inversed relationship between soy IFs consumption 
and breast cancer risk. Further support is the observation that after adaption 
of western diets in Asian woman who emigrated to the U.S.A the lower breast 
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cancer risk is lost. Indicating that the differences between the populations are 
about environmental- rather than genetic factors (Tham et al., 1998). Other 
support is that vegetarians, who in general consume more soy products and 
less animal products, also have a lower risk of gaining breast cancer (Duncan 
et al., 2003).  
7.1.2 Colon and prostate cancer 
Like breast cancer, colon and prostate cancer is also less frequent in men 
from Asian populations compared to those in western countries. High intake 
of IFs is proven by the higher concentration found in biological fluids of Asian 
men compared to European and western counterparts (Duncan et al., 2003).   
7.2 Cardiovascular disease 
There are many risk factors for development of cardiovascular disease, and 
hormonal status is one that is known (Bakker 2004). Many studies have ben 
able to show a relationship between IF consumption and low risk of cardio-
vascular disease (Tham et al., 1998).  Consumption of soy may lower choles-
terol levels, but if the IFs are responsible for this is still unclear (Bakker, 
2004). 
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8 Discussion 
 
The aim of this article was to review the most common isoflavones and me-
tabolites. Since we have seen that these substances vary amongst themselves 
in metabolic fates and nutritional sources it is relevant to observe closer the 
consumer patterns of these phytochemicals. Research on soybean and soy 
foodstuffs is extensive due to their high IF content. That IFs have the ability to 
generate effects on the host post ingestion seems to be out of discussion. 
However there are many contradictory results wheatear these are negative or 
positive, and to which extent. Given that the consumption levels vary to be 
high in the east and the fact that hormone related conditions are low in the 
populations, it is important to discuss the bioavailability and content in dif-
ferent foodstuffs.  
Evaluation of the IF’s health effects is complex and observation studies can be 
difficult, as it is not only the consumed IFs contents that differ between the 
populations, but entire diets.  Further research is needed to evaluate the ab-
solute effects of these compounds as well as the attributes of the individuals 
who would perhaps benefit from these. Many, if not most, studies discuss the 
positive health effects generated from IFs and their metabolites. There are 
many discussing the positive health effects regarding prevention of hormone 
induced cancers, such as breast cancer and prostate cancer, also other hor-
mone related diseases and conditions such as cardiovascular diseases, osteo-
porosis, and menopausal difficulties. The studies that present negative health 
effects should also be investigated further.   
When analyzing the effects of a single component in a foodstuff it is important 
to consider its complexity and that other factors may be responsible for any 
positive or negative health effect.  
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Since much interest has fallen on the metabolites for their activity it seems 
only reasonable that sources for these are discussed. Bovine milk could be a 
source for eqoul for non-equol producers. Other foodstuff of animal origin 
could also be discussed as a potential source of IF metabolites. 
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